~23 spots leftby Mar 2028

Spinal Cord Stimulation + Respiratory Training for Spinal Cord Injury

AW
Overseen ByAndrea Willhite, MS
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: University of Louisville
Disqualifiers: Pulmonary, Cardiovascular, Endocrine, Obesity, others
No Placebo Group

Trial Summary

What is the purpose of this trial?

Respiratory complications are among the leading causes of death in patients with chronic spinal cord injury (SCI). Our previous work showed that pulmonary function can be improved by using our original respiratory training method. However, the effectiveness of this intervention is limited due to the disruption of brain-spinal connections and consequently lowered spinal cord activity below the injury level. Our recent studies showed that electrical stimulation of the spinal cord below the level of injury leads to increased ventilation which indicates activation of the spinal cord structures related to respiration. These findings indicate that spinal cord stimulation can be a promising therapeutic additive to the treatment. The goal of this study is to justify the establishment of a new direction in rehabilitation for patients with SCI by using a non-invasive spinal cord stimulation in combination with respiratory training. Our aims are: 1) to evaluate the effects of such stimulation applied to the injured spinal cord on pulmonary function and respiratory muscle activity, and 2) to evaluate the effectiveness and therapeutic mechanisms of the spinal cord stimulation combined with respiratory training. Thirty-six individuals with chronic SCI will be recruited and assigned to three groups to receive respiratory training or spinal cord stimulation alone or a combination of them. All participants will be tested before and after cycles of experimental procedures with/or without stimulation. Our hypotheses will be confirmed if the respiratory training combined with spinal cord stimulation results in the most enhanced positive effects.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Spinal Cord Stimulation + Respiratory Training for Spinal Cord Injury?

Research shows that combining transcutaneous spinal cord stimulation (tSCS) with inspiratory muscle training (IMT) significantly improves breathing and coughing abilities in people with cervical spinal cord injury, compared to IMT alone. Additionally, respiratory muscle strength training has been shown to improve muscle strength by up to 50% in various populations, including those with spinal cord injury.12345

Is spinal cord stimulation combined with respiratory training safe for humans?

Research indicates that inspiratory muscle training and spinal cord stimulation are generally safe for individuals with spinal cord injuries, as studies have shown improvements in respiratory function without significant adverse effects.12467

How does the treatment Spinal Cord Stimulation + Respiratory Training for Spinal Cord Injury differ from other treatments?

This treatment is unique because it combines respiratory training with transcutaneous spinal cord stimulation (tSCS), which is a non-invasive method that uses electrical stimulation to improve respiratory muscle strength and function. Unlike other treatments that may focus solely on respiratory exercises, this approach aims to enhance recovery by stimulating the spinal cord to improve breathing and coughing abilities in patients with spinal cord injuries.14689

Research Team

AO

Alexander Ovechkin, MD, PhD

Principal Investigator

University of Louisville

Eligibility Criteria

This trial is for adults over 18 with chronic spinal cord injury (SCI) who have been stable for at least a year and show significant breathing function deficits. It's not suitable for those dependent on ventilators, with major illnesses like heart disease or cancer, obesity, pregnancy, or conditions that could interfere with the training.

Inclusion Criteria

I don't have any major muscle or bone issues, open wounds, or UTIs that could affect my breathing exercises.
I am 18 years old or older.
Your lung function test shows at least a 15% decrease compared to what is typical for a healthy person.
See 4 more

Exclusion Criteria

I have an illness related to HIV/AIDS.
I do not have major esophageal or gastrointestinal issues that would prevent me from undergoing respiratory training or testing.
I have low blood pressure due to another health condition.
See 7 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2 weeks

Baseline Assessment

Participants undergo baseline assessments before the intervention

2 weeks

Intervention

Participants receive 80 sessions of Respiratory Training, Spinal Cord Transcutaneous Stimulation, or a combination of both

16 weeks
80 sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment

16 weeks

Treatment Details

Interventions

  • Respiratory Training (Behavioural Intervention)
  • Transcutaneous spinal cord stimulator (Procedure)
Trial OverviewThe study tests if non-invasive spinal cord stimulation combined with respiratory training can improve lung function in SCI patients. Participants are divided into three groups to receive either just the training, just the stimulation, or both together.
Participant Groups
3Treatment groups
Experimental Treatment
Active Control
Group I: Spinal Cord Transcutaneous Stimulation and Respiratory Training (scTS+RT) groupExperimental Treatment2 Interventions
Participants will undergo 80 scTS combined with the RT while seated in their own wheelchairs with an approximately 45° head-up tilt. The scTS will be administered using the Neostim/Biostim (Cosyma Inc., Denver CO) and Standard threshold Positive Expiratory Pressure Device (PEP, Respironics Inc., Cedar Grove, NJ) and standard threshold Inspiratory Muscle Trainer (IMT, Respironics Inc., Cedar Grove, NJ) assembled together using a T-shaped connector with a flanged mouthpiece (Airlife 001504) will be used for the RT as described for the Arms 1 and 2.
Group II: Training (RT) groupActive Control1 Intervention
80 scTS sessions will be administered using the Neostim/Biostim (Cosyma Inc., Denver CO) device applying up to five conductive electrodes placed on the skin at the midline over the thoracic levels as cathodes between T1 to T8, and up to four self-adhesive electrodes located symmetrically on the skin over the iliac crests and shoulders as anodes. During the intervention, optimally configured scTS will be delivered based on the measures assessed during mapping sessions. The scTS with 5 mA-sub-motor threshold intensity with optimal frequency and pulse width will be delivered using 5 min on and 5 min off stimulation periods during interventional bouts. Every research participant will be slowly acclimated to stimulation. Blood pressure, heart rate, and respiratory rate will be closely monitored throughout stimulation sessions in the Lab by using beat-to-beat blood pressure, and respiratory kinematics monitoring.
Group III: Spinal Cord Transcutaneous Stimulation (scTS) groupActive Control1 Intervention
Participants will undergo 80 RT sessions using standard threshold Positive Expiratory Pressure Device (PEP, Respironics Inc., Cedar Grove, NJ) and standard threshold Inspiratory Muscle Trainer (IMT, Respironics Inc., Cedar Grove, NJ) assembled together using a T-shaped connector with a flanged mouthpiece (Airlife 001504). Participants will be trained at the Frazier Rehab Institute and remotely to complete eighty 45-minute sessions during 16 weeks. The participants will be instructed to perform inspiratory and expiratory efforts against a pressure threshold load. The training will be initiated with a load equal to 20% of their individual Maximum Inspiratory Pressure (PImax) and Maximum Expiratory Pressure (PEmax) values with progressive increases as tolerated up to 60% of their baseline PImax and PEmax measures. The goal will be to reach the 60% load of PImax and PEmax during the last week of each month of the training.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Louisville

Lead Sponsor

Trials
353
Recruited
76,400+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

Findings from Research

In a randomized controlled trial with 22 cervical spinal cord injury (cSCI) subjects, transcutaneous spinal cord stimulation (tSCS) combined with inspiratory muscle training (IMT) significantly improved respiratory function, including reduced breathlessness and increased thoracic muscle strength.
Subjects receiving tSCS + IMT showed notable enhancements in maximum inspiratory pressure, maximum expiratory pressure, and forced vital capacity, while those who only underwent IMT did not experience significant changes, highlighting the potential of tSCS as an effective adjunct therapy for respiratory rehabilitation in cSCI.
Transcutaneous Spinal Cord Stimulation Improves Respiratory Muscle Strength and Function in Subjects with Cervical Spinal Cord Injury: Original Research.Kumru, H., García-Alén, L., Ros-Alsina, A., et al.[2023]
Inspiratory muscle training (IMT) was found to be feasible and safe for seven adult patients with acute complete cervical or thoracic spinal cord injuries, with all planned sessions successfully delivered without any adverse events.
Some participants showed improvements in lung function, with increases in maximal inspiratory pressure for four individuals and forced vital capacity for three, suggesting potential efficacy of IMT in enhancing respiratory function.
Inspiratory muscle training is feasible and safe for patients with acute spinal cord injury.McDonald, T., Stiller, K.[2020]
A 4-week expiratory muscle strength training program, using a pressure threshold device, showed up to a 50% improvement in respiratory muscle strength among healthy individuals and those with conditions like multiple sclerosis and spinal cord injury.
The training protocol, which involves 15-20 minutes of daily exercises five times a week, is designed to enhance expiratory muscle strength and may also positively impact functional outcomes and brain plasticity.
Respiratory muscle strength training: functional outcomes versus plasticity.Sapienza, CM., Wheeler, K.[2022]

References

Transcutaneous Spinal Cord Stimulation Improves Respiratory Muscle Strength and Function in Subjects with Cervical Spinal Cord Injury: Original Research. [2023]
Inspiratory muscle training is feasible and safe for patients with acute spinal cord injury. [2020]
Respiratory muscle strength training: functional outcomes versus plasticity. [2022]
Lower thoracic spinal cord stimulation to restore cough in patients with spinal cord injury: results of a National Institutes of Health-sponsored clinical trial. Part I: methodology and effectiveness of expiratory muscle activation. [2021]
Respiratory muscle training for cervical spinal cord injury. [2022]
Electrical activation of the expiratory muscles to restore cough. [2007]
Community exercise for individuals with spinal cord injury with inspiratory muscle training: A pilot study. [2022]
Optimizing sensory fiber activation during cervical transcutaneous spinal stimulation using different electrode configurations: A computational analysis. [2022]
Respiratory Training and Plasticity After Cervical Spinal Cord Injury. [2022]